Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases
S Pramanik, S Mohanto, R Manne… - Molecular …, 2021 - ACS Publications
Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …
Intraperitoneal aerosolized drug delivery: technology, recent developments, and future outlook
M Rahimi-Gorji, L Van de Sande, C Debbaut… - Advanced Drug Delivery …, 2020 - Elsevier
Current therapies for patients with peritoneal metastases (PM) are only moderately effective.
Recently, a novel locoregional treatment method for PM was introduced, consisting of a …
Recently, a novel locoregional treatment method for PM was introduced, consisting of a …
CO2-Driven Nebulization of pH-Sensitive Supramolecular Polymers for Intraperitoneal Hydrogel Formation and the Treatment of Peritoneal Metastasis
H Braet, PP Fransen, R Mariën, G Lollo… - … Applied Materials & …, 2023 - ACS Publications
Because peritoneal metastasis (PM) from ovarian cancer is characterized by non-specific
symptoms, it is often diagnosed at advanced stages. Pressurized intraperitoneal aerosol …
symptoms, it is often diagnosed at advanced stages. Pressurized intraperitoneal aerosol …
The effect of electrostatic high pressure nebulization on the stability, activity and ex vivo distribution of ionic self-assembled nanomedicines
H Braet, V Andretto, R Mariën, B Yücesan… - Acta Biomaterialia, 2023 - Elsevier
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is applied to treat unresectable
peritoneal metastasis (PM), an advanced, end-stage disease with a poor prognosis …
peritoneal metastasis (PM), an advanced, end-stage disease with a poor prognosis …
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: systematic review of clinical and experimental evidence with special …
C Tempfer, U Giger-Pabst, Z Hilal, A Dogan… - Archives of gynecology …, 2018 - Springer
Background Systemic chemotherapy is not effective in patients with peritoneal
carcinomatosis (PC) and only a minority of affected patients is eligible for cytoreductive …
carcinomatosis (PC) and only a minority of affected patients is eligible for cytoreductive …
Synergy between intraperitoneal aerosolization (PIPAC) and cancer nanomedicine: cisplatin-loaded polyarginine-hyaluronic acid nanocarriers efficiently eradicate …
M Shariati, G Lollo, K Matha, B Descamps… - … applied materials & …, 2020 - ACS Publications
Intra-abdominal dissemination of peritoneal nodules, a condition known as peritoneal
carcinomatosis (PC), is typically diagnosed in ovarian cancer patients at the advanced …
carcinomatosis (PC), is typically diagnosed in ovarian cancer patients at the advanced …
Current trends in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal disease from appendiceal and colorectal …
MM Harper, J Kim, PK Pandalai - Journal of clinical medicine, 2022 - mdpi.com
Peritoneal carcinomatosis (PC) is a poor prognostic factor for all malignancies. This extent of
metastatic disease progression remains difficult to treat with systemic therapies due to poor …
metastatic disease progression remains difficult to treat with systemic therapies due to poor …
Pressurized intraperitoneal aerosol chemotherapy (PIPAC): updated systematic review using the IDEAL framework
AE Baggaley, GBRC Lafaurie, SJ Tate… - British Journal of …, 2023 - academic.oup.com
Methods This systematic review was conducted with the MEDLINE and Embase databases,
up to 28 February 2022. Included studies were assigned a stage (0, 1, 2a, 2b, 3, or 4), using …
up to 28 February 2022. Included studies were assigned a stage (0, 1, 2a, 2b, 3, or 4), using …
Performance of different nebulizers in clinical use for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
D Göhler, K Oelschlägel, M Ouaissi, U Giger-Pabst - Plos one, 2024 - journals.plos.org
Objective Technical ex-vivo comparison of commercial nebulizer nozzles used for
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Methods The performance of …
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Methods The performance of …
The onset of in-vivo dehydration in gas-based intraperitoneal hyperthermia and its cytotoxic effects on colon cancer cells
A Diakun, T Khosrawipour… - Frontiers in …, 2022 - frontiersin.org
Background Peritoneal metastasis (PM) is an ongoing challenge in surgical oncology.
Current therapeutic options, including intravenous and intraperitoneal (ip) chemotherapies …
Current therapeutic options, including intravenous and intraperitoneal (ip) chemotherapies …